LGND (Ligand Pharmaceuticals) Days Payable : 159.65 (As of Dec. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Ligand Pharmaceuticals Days Payable?

Ligand Pharmaceuticals's average Accounts Payable for the three months ended in Dec. 2024 was $5.0 Mil. Ligand Pharmaceuticals's Cost of Goods Sold for the three months ended in Dec. 2024 was $2.8 Mil. Hence, Ligand Pharmaceuticals's Days Payable for the three months ended in Dec. 2024 was 159.65.

The historical rank and industry rank for Ligand Pharmaceuticals's Days Payable or its related term are showing as below:

LGND' s Days Payable Range Over the Past 10 Years
Min: 35.77 Med: 130.26 Max: 370.25
Current: 105.74

During the past 13 years, Ligand Pharmaceuticals's highest Days Payable was 370.25. The lowest was 35.77. And the median was 130.26.

LGND's Days Payable is ranked worse than
54.2% of 703 companies
in the Biotechnology industry
Industry Median: 122.89 vs LGND: 105.74

Ligand Pharmaceuticals's Days Payable increased from Dec. 2023 (136.29) to Dec. 2024 (159.65). It may suggest that Ligand Pharmaceuticals delayed paying its suppliers.

Ligand Pharmaceuticals Days Payable Historical Data

The historical data trend for Ligand Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ligand Pharmaceuticals Days Payable Chart

Ligand Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

37.22

35.77

47.36

134.27

126.24

Ligand Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Days Payable	Get a 7-Day Free Trial															136.29	68.39	57.87	120.85	159.65

Competitive Comparison of Ligand Pharmaceuticals's Days Payable

For the Biotechnology subindustry, Ligand Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ligand Pharmaceuticals's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ligand Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Ligand Pharmaceuticals's Days Payable falls into.

Save Embed

;

Save Embed

;

Ligand Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Ligand Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (2.427	+	5.233)	/	2 )	/	11.074	*	365
=	3.83					/	11.074	*	365
=	126.24

Ligand Pharmaceuticals's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

	Days Payable (Q: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2024 )	+	Accounts Payable (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (4.694	+	5.233)	/	2 )	/	2.837	*	365 / 4
=	4.9635					/	2.837	*	365 / 4
=	159.65

Ligand Pharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of Ligand Pharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Ligand Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ligand Pharmaceuticals Inc (NAS:LGND) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

LGDN:Germany LGDN:Germany

Address

555 Heritage Drive, Suite 200, Jupiter, FL, USA, 33458

Website

https://www.ligand.com

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Executives

Octavio Espinoza	officer: Chief Financial Officer	C/O LIGAND PHARMACEUTICALS INC, 3911 SORRENTO VALLEY BOULEVARD, STE 110, SAN DIEGO CA 92121
John L Lamattina	director	81 WYMAN ST, POST OFFICE BOX 9046, WALTHAM MA 02454
Andrew Reardon	officer: CHIEF LEGAL OFFICER &	C/O LIGAND PHARMACEUTICALS INCORPORATED, 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO CA 92121
Matthew E Korenberg	officer: VP, Finance and CFO	11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
Todd C Davis	director	11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
Nancy Ryan Gray	director	C/O LIGAND PHARMACEUTICALS INCORPORATED, 3911 SORRENTO VALLEY BOULEVARD, STE 110, SAN DIEGO CA 92121
Stephen L Sabba	director	DORSET MANAGEMENT CORP, 485 UNDERHILL BLVD SUITE 205, SYOSSET NY 11791
Martine Zimmermann	director	C/O LIGAND PHARMACEUTICALS INCORPORATED, 3911 SORRENTO VALLEY BOULEVARD SUITE 110, SAN DIEGO CA 92121
John W Kozarich	director	10275 SCIENCE CENTER DR, SAN DIEGO CA 92121
John L Higgins	officer: CEO & President	11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
Jason Haas	director	C/O SYROS PHARMACEUTICALS, INC., 35 CAMBRIDGEPARK DRIVE, CAMBRIDGE MA 02140
Matthew W Foehr	officer: EVP and COO	11119 NORTH TORREY PINES RD #200, LA JOLLA CA 92037
Jennifer R. Cochran	director	C/O LIGAND PHARMACEUTICALS INC, 3911 SORRENTO VALLEY BOULEVARD, STE 100, SAN DIEGO CA 92121
Charles S Berkman	officer: Asso. Gen. Counsel, Secretary	11085 NORTH TORREY PINES ROAD, SUITE 300, LA JOLLA CA 92037
Sunil Patel	director	11085 NORTH TORREY PINES RD., SUITE 300, LA JOLLA CA 92037